University of North Carolina Chapel Hill — Chapel Hill, North Carolina

Public research footprint of University of North Carolina Chapel Hill, compiled from the ClinicalTrials.gov public registry.

479

Registered studies

Active

Recruiting now

331

Completed

Stopped or withdrawn

Most-studied conditions

Lymphoma · Breast Cancer · Immune System Diseases · Early Parkinson Disease (Early PD)

Recently updated registry entries

NCT03696784 — Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma (Active Not Recruiting)
NCT07340541 — Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies (Recruiting)
NCT04363684 — ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of North Carolina Chapel Hill?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.